EssilorLuxottica acquires Optegra clinics with support from MidEuropa
The Optegra platform currently operates in the Czech Republic, the Netherlands, Poland, Slovakia and the United Kingdom
Metabolomic profiling could identify stage-specific diabetic retinopathy biomarkers
Lysine, proline and arginine levels progressively increased from non-proliferative DR to proliferative DR stages
Early uveitis detection and intervention is key to vision preservation, systemic health
New clinical guidance for anterior and posterior uveitis was published by a research team from the University of Bristol
Early intervention is crucial for long-term outcomes in paediatric gene therapy
At the Retina World Congress, we spoke with Siegfried Priglinger, MD, about ensuring the best outcomes for preschool-aged patients
Research indicates B vitamins and choline provide neuroprotection against glaucoma
Vitamins B6, B9 and B12 were found to be neuroprotective against retinal ganglion cell death
Robert Ang, MD, explains why a small-aperture IOL is "not a niche product"
At the 2025 ASCRS meeting, Dr Ang said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Jorge Alió, MD, PhD, FEBOphth, FWCRS, receives 2024 International Research Excellence Award
Prof Alió was commended for his work in microincisional cataract surgery and accommodative IOLs for presbyopia
EMA issues CE mark for DREAM OCT (Intalight)
The OCT platform offers deep imaging depth, rapid sweeping speed, extensive scan range, accurate results and multimodal imaging capabilities
ARVO 2025: Ocular and systemic mitochondrial diseases may be key to dementia diagnosis
Detecting mitochondrial dysfunction may give clinicians a chance to reduce the rate of cognitive decline in patients with dementia
Research links COVID-19 to prevalence and severity of paediatric astigmatism
The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren
Topline results from investigational nAMD drop SYL1801 (Sylentis)
Three dose level cohorts of the small interfering RNA therapeutic were evaluated in a double-blind study
How patients navigate quality-of-life challenges associated with geographic atrophy
Investigators sought to understand the diagnostic path, symptoms, quality of life impact and coping mechanisms of patients with GA in western Europe and the United States
AAVantgarde Bio presents positive data for retinitis pigmentosa and Stargardt disease therapies
The company shared results from the AAVB-081 clinical programme and AAVB-039 preclinical programme at ARVO
EyeCool Therapeutics announces results from pilot study of novel chronic ocular surface pain treatment
The investigational device, ETX-4143, was the focus of a study involving 31 patients with COSP in Australia
Retinal microvascular changes in patients with systemic lupus erythematosus: Importance of OCTA
The biomarkers are especially crucial for patients with lupus nephritis
Topcon Healthcare, Inc. appoints Krysten Williams Head of Digital Solutions & Clinical Development – EMEA
Williams joins Topcon Healthcare from Heidelberg Engineering, where she held multiple senior leadership roles.
Teprotumumab (Tepezza, Amgen) receives marketing authorisation from MHRA
Teprotumumab is the first therapy specifically licensed for the treatment of moderate-to-severe thyroid eye disease in the UK
ARVO 2025: Alfredo Sadun, MD, PhD, says "later is better" for some LHON interventions
At the 2025 ARVO annual meeting, Prof Sadun shared an exciting update in our understanding of Leber hereditary optic neuropathy
Moorfields, Topcon, IoO announce partnership launch of Cascader
Utilizing artificial intelligence (AI), Cascader is a new medical technology company that aims to transform the detection and management of eye disease.
ARVO 2025: Nitish Mehta, MD, provides real-world insights from aflibercept 8 mg for treatment-naive diabetic macular oedema
ARVO 2025: Anat Loewenstein, MD, and colleagues on meeting needs of patients with diabetic retinopathy
Prof Loewenstein and a cohort of colleagues assessed the current treatment outlook for patients with diabetic retinopathy
Editorial Advisory Board members bring research findings to ARVO
Members of the Ophthalmology Times Europe, Ophthalmology Times and Modern Retina editorial advisory boards are present and presenting at the 2025 ARVO meeting
ZEISS debuts Research Data Platform, highlights Boehringer Ingelheim partnership
Carl Zeiss Meditec plans to launch the ZEISS RDP in select countries throughout 2025
LuxIA receives CE-MDR certification
LuxIA is designed to screen adult diabetic patients for more-than-mild diabetic retinopathy.
EMA CHMP adopts positive opinion for teprotumumab (Tepezza, Amgen) marketing authorisation application
In the weeks to come, the European Commission will issue a decision on the first severe thyroid eye disease treatment
The future of microbial keratitis treatment is bright
Ultraviolet light’s potential in ocular care extends beyond structural reinforcement to antimicrobial applications, especially for microbial keratitis
Sheng Lim, MD, FRCOphth, brings data from the CONCEPT study to the ASCRS meeting
Endoscopic cyclophotocoagulation (ECP) has major potential for patients with glaucoma
Vision- and life-threatening neuro-ophthalmological presentations
Paediatric diagnoses of juvenile idiopathic intracranial hypertension, optic neuritis and Horner syndrome
Diagnosing types of dry eye in patients with autoimmune disease
ENTOD Pharmaceuticals announces CDSCO approval of 0.05% atropine drops (Myatro XL)
According to a press release, Myatro XL is the first 0.05% atropine eye drop for paediatric myopia control.
